Ann: Suspension from Quotation, page-12

Of course, and that is the punt - this company being a going concern has been a risk for a while.

Some investors with similar going concerns were selling stock (on the same quotation basis, amidst the madness) for as low as $0.06 cents to get out of similar risk on 25 March, only to see the stock trade as high as $0.755 on the following day on the Vietnemese/Singapore approvals.

OSX was more of risk on a going concern basis before that announcement. The suspension in quotation is for failures in periodic reporting - not its threat of continuing to be an ongoing concern. It is not alone in its suspension on the ASX for that reasoning at the moment and other companies have faced similar situations historically and continued to list/operate thereafter.

Don't underestimate the shortfall facility. This company is worth dust on likely implied mkt cap. Not much for a big investment house to throw a cool few million at it in a takeover at cellar prices. Remove this atrocious management team and take the tech (far more than just its aXOpore technology - granted regulatory clearance by Singapore’s Health Sciences Authority and Vietnam’s Department of Medical Equipment and Construction) and sales network for peanuts.

I'd loosely estimate its something like a 3-1 to 10-1 payout on capital in a year, for a 50-50 chance of survival as an ASX listed company / taken over company in a years time. You have to play the pot vs the odds with those poker hands.